Motilal Oswal has maintained its 'Neutral' rating on Alkyl Amines Chemicals with a target price of ₹1,690. The decision follows a strong Q2 performance where the company reported a significant increase in EBITDA and net profit. While the company shows steady growth potential in the pharma and agrochemical sectors, the brokerage's neutral stance balances this growth against the stock's current valuation.
Brokerage firm Motilal Oswal has maintained a 'Neutral' rating on Alkyl Amines Chemicals, setting a price target of ₹1,690 per share. This target is based on the company's projected earnings for the fiscal year 2028. The firm's outlook follows a solid operational performance in the second quarter of fiscal year 2027, where Alkyl Amines reported a standalone net profit of ₹65.2 crore, up significantly from ₹43 crore in the same period a year ago.
Operational Performance and Drivers
Alkyl Amines reported a strong second quarter, marked by a 39% year-on-year rise in EBITDA. This growth was supported by the company's ability to pass on raw material costs effectively and the benefits of operating leverage, which helped expand profit margins. The company's future growth strategy remains tied to key industrial sectors. Rising demand from the pharmaceutical industry, particularly for peptide production, is a major focus area for the company. Additionally, sustained demand from agrochemical and rubber chemical segments continues to support volume growth. The management is actively trying to gain market share in its core product lines while investing in new categories to diversify its revenue base.
Financial Context and Valuation
Motilal Oswal analysts have projected a compound annual growth rate of 16% for revenue and 27% for profit after tax through fiscal year 2028. The brokerage has revised its earnings estimates for the coming years upward, signaling confidence in the company's operational trajectory. A key strength for Alkyl Amines is its balance sheet, as the company remains nearly debt-free, which provides it with financial flexibility. Despite these positive indicators, the 'Neutral' stance suggests that the brokerage views the stock as fairly valued at its current price levels based on their 30x FY28 earnings multiple.
Risks and Market Factors
Investors should be aware of several factors that could influence future performance. The chemical sector is sensitive to fluctuations in raw material prices, such as ammonia, methanol, and ethanol. Any significant volatility in these input costs can squeeze profit margins if the company cannot pass them on to customers. Furthermore, the company faces risks related to a potential moderation in demand from its end-user industries like pharmaceuticals and agrochemicals. Increased competition and global supply chain disruptions also remain relevant factors for the specialty chemicals sector. Investors may want to track these demand trends and raw material cost movements, as they will determine whether the company can maintain its current growth momentum in the upcoming quarters.